CHAMPIONS ONCOLOGY, INC. Deferred Tax Assets, Operating Loss Carryforwards, Foreign
CHAMPIONS ONCOLOGY, INC. (CSBR) had Deferred Tax Assets, Operating Loss Carryforwards, Foreign of $0 as of 2019-04-30, per its 10-K filed 2019-07-29.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign · last filed 2019-07-29
- 2019-04-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $0.00.
- 2018-04-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $208.00K.
- 2017-04-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $214.00K.
- 2016-04-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $224.00K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign as first filed |
|---|---|---|
| 2019-04-30 | $0.00 10-K · filed 2019-07-29 | |
| 2018-04-30 | $208.00K 10-K · filed 2019-07-29 | |
| 2017-04-30 | $214.00K 10-K · filed 2018-07-30 | |
| 2016-04-30 | $224.00K 10-K · filed 2017-07-28 | |
| 2015-04-30 | $235.00K 10-K · filed 2016-07-29 | |
| 2014-04-30 | $244.00K 10-K · filed 2015-07-29 | |
| 2013-04-30 | $386.00K 10-K · filed 2014-07-28 | $365.00K 10-K · filed 2013-07-26 |
| 2012-04-30 | $265.00K 10-K · filed 2013-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |